156755-20-3

Basic information

• Product Name: PNU 200577 l-mandelate salt
• Synonyms: PNU 200577 l-mandelate salt
• CAS NO: 156755-20-3
• Molecular Weight: 493.643
• Mol File: 156755-20-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: PNU 200577 l-mandelate salt(CAS DataBase Reference)
• NIST Chemistry Reference: PNU 200577 l-mandelate salt(156755-20-3)
• EPA Substance Registry System: PNU 200577 l-mandelate salt(156755-20-3)

Safety Data

• Hazardous Substances Data: 156755-20-3(Hazardous Substances Data)

Upstream product

• 1390644-47-9 (R)-3-(3-(diisopropylamino)-1-phenylpropyl)-4-hydroxybenzyl acetate 
• 1390644-45-7 (R)-4-(bromomethyl)-2-(3-(diisopropylamino)-1-phenylpropyl)phenol 
• 1203453-91-1 (R)-2-(3-amino-1-phenylpropyl)-4-(hydroxymethyl)phenol 
• 1390644-44-6 4-(hydroxymethyl)-2-((R)-1-phenyl-3-((R)-1-phenylethylamino)propyl)phenol 
• 1390644-43-5 4-hydroxy-3-((R)-3-oxo-1-phenyl-3-((R)-1-phenylethylamino)propyl)benzoic acid 
• 156755-33-8 (R)-4-(benzyloxy)-3-(3-(diisopropylamino)-1-phenylpropyl)benzoic acid hydrochloride 
• 250214-37-0 (+/-)-toluene-4-sulphonic acid 3-(2-benzyloxy-5-bromophenyl)-3-phenylpropyl ester 
• 156755-24-7 methyl 3-[2-(benzyloxy)-5-bromophenyl]-3-phenylpropanoate 
• 156755-37-2 {4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]phenyl}methanol 
• 156755-23-6 6-bromo-4-phenyl-3,4-dihydro-2H-chromen-2-one 
• 286930-05-0 (+)-N,N-Diisopropyl-3-(2-benzyloxy-5-carbomethoxyphenyl)-3-phenylpropylamine 
• 356782-33-7 (R,S)-4-phenyl-2-chromanone-6-carboxylic acid 
• 621-82-9 Cinnamic acid 
• 106-41-2 4-bromo-phenol 

Downstream Products

• 1390644-38-8 (R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxylmethyl)phenylmethacrylate mandelate 
• 286930-02-7 fesoterodine 
• 286930-03-8 fesoterodine fumarate 
• 1390644-34-4 isobutyric acid 2-((R)-3-diisopropylammonium-1-phenyIpropyl)-4-(hydroxymethyl)phenyl ester (R)-acetoxy(phenyl)acetate 
• 1390644-37-7 (R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxylmethyl)phenyl methacrylate 

Relevant articles and documents

PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST

The present invention relates to novel and improved processes for the preparation of (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenylisobutyrate represented by the following structural formula-1 and its pharmaceutically acceptable salts thereof.

Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine

A process is described for the preparation of 3-(5-formyl-2-hydroxyphenyl)-3-phenylpropylamine derivatives, intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.